506 ·
670,
671
Monte, AP; Marona-Lewicka, D; Lewis, MM; Mailman, RB; Wainscott, DB; Nelson, DL; Nichols, DE. Substituted naphthofurans as hallucinogenic phenethylamine—ergoline hybrid molecules with unexpected muscarinic antagonist activity J. Med. Chem., 1 Jun 1998, 41 (12), 2134–2145. 258 kB. https://doi.org/10.1021/jm980076u #4a,b MS,NMR
Chambers, JJ. Use of conformationally-restricted analogues and homology modeling to provide insight into the nature of the 5-HT2A receptor agonist binding site Ph. D. Thesis, Purdue University, West Lafayette, IN, 1 Jan 2002. 8.4 MB. #8, X = H MS,NMR,other
Monte, AP. Structure-activity relationships of hallucinogens: Design, synthesis, and pharmacological evaluation of a series of conformationally restricted phenethylamines Ph. D. Thesis, Purdue University, West Lafayette, IN, 1 Aug 1995. 10.7 MB. #1, 2 MS,NMR
2C-YN · 4-Ethynyl-2,5-dimethoxyphenethylamine
α-Cyclopropyl-3,4-methylenedioxyphenethylamine · α-cPr-3,4-MDPEA · α-iPr-3,4-MDPEA
DMMH-2 · Dehydrosalsolidine
α-Allyl-3,4-methylenedioxyphenethylamine
4-Ethynyl-3,5-dimethoxyphenethylamine · DYN
N-Formyl-N,4-dimethylcathinone · N-Formyl-mephedrone
2,4,6-Trimethyl-β-methyl-β-nitrostyrene